期刊
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
卷 38, 期 9, 页码 581-584出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/cbr.2023.0112
关键词
trust in artificial intelligence; precision versus personalized oncology; phronesis; shared-care
This article discusses the issue of trust in AI chatbots for cancer patients and proposes a shared-care approach that combines technical precision with holistic care by physicians.
Trust, as a philosophic paradigm, is predominantly interpersonal, between human beings, and is differentiated from reliance. Can a person trust an inhumane amoral agent, such as a large language model artificial intelligence (AI) chatbot, to manifest the goodwill and willingness normally required in order for it to be deemed trustworthy? This article explores the relationship between the cancer patient, their physician, and AI chatbot in a proposed tripartite, consultative, personalized approach to shared-care in precision molecular oncology. It examines the nature of trust between human agents and machines. It also contemplates AI-enhanced technical precision in state-of-the-art cancer management, complemented by trustworthy, holistic clinical care by a physician, for each individual patient. To what extent can the user trust GPT-4? Peter Lee,1 Microsoft Research 2023
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据